Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Andréanne Zizzo"'
Autor:
Pushpa Sathya, Jessica T. Hochberg, Wael El-Matary, Nadia Ovchinsky, Ruchi Singh, Trevor J. Laborda, Douglas Mogul, Matthew DiGuglielmo, Simon Horslen, Emily R. Perito, Maureen M. Jonas, Alexander Miethke, Bart G. P. Koot, Kathleen B. Schwarz, Girish S. Rao, Nitika A. Gupta, Pamela L. Valentino, Cara L. Mack, Mark Deneau, Katryn N. Furuya, Amanda Ricciuto, M. Kyle Jensen, Laura G. Draijer, Nanda Kerkar, Uzma Shah, Achiya Z. Amir, Stephen L. Guthery, Kathleen M. Loomes, Mercedes Martinez, Tamir Miloh, Andréanne Zizzo, Saeed Mohammad, Christine K. Lee, Bernadette Vitola
Publikováno v:
Hepatology
Background and aims Many children with primary sclerosing cholangitis (PSC) receive oral vancomycin therapy (OVT) or ursodeoxycholic acid (UDCA). There is a paucity of data on whether these medications improve outcomes. Approach and results We analyz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acf3b2ebfb947e045c1ea79b0999907f
https://europepmc.org/articles/PMC8557636/
https://europepmc.org/articles/PMC8557636/
Autor:
Matjaz Homan, Binita M. Kamath, Bart G. P. Koot, Mansi Amin, Parvathi Mohan, Amanda Ricciuto, Melissa Zerofsky, Madeleine Aumar, Kathleen B. Schwarz, Laura G. Draijer, Annemarie Broderick, Kaija-Leena Kolho, Stephen L. Guthery, Nanda Kerkar, Saeed Mohammad, Nisreen Soufi, Alexandra Papadopoulou, Eyal Shteyer, Raffaele Iorio, Nadia Ovchinsky, M. Kyle Jensen, Simon Horslen, Ruchi Singh, Maureen M. Jonas, Kyung Mo Kim, Alexander Miethke, Girish S. Rao, Federica Ferrari, Achiya Z. Amir, Cara L. Mack, Douglas Mogul, Matthew DiGuglielmo, Vratislav Smolka, Christine K. Lee, Pushpa Sathya, Katryn N. Furuya, Nitika A. Gupta, Mercedes Martinez, Atsushi Tanaka, Tamir Miloh, Kathleen M. Loomes, Bernadette Vitola, Uzma Shah, Pamela L. Valentino, Andréanne Zizzo, Mark Deneau, Jessica T. Hochberg, Wael El-Matary, Stacy Moroz, Marcus Auth, Emily R. Perito, Trevor J. Laborda, Marek Woynarowski, Eleonora Druve Tavares Fagundes, Alexandre Rodrigues Ferreira, Raghu Varier, Sirish Palle
Publikováno v:
Hepatology (Baltimore, Md.), 73(3), 1074-1087. John Wiley and Sons Ltd
Paediatrics Publications
Paediatrics Publications
Background and Aims: Disease progression in children with primary sclerosing cholangitis (PSC) is variable. Prognostic and risk-stratification tools exist for adult-onset PSC, but not for children. We aimed to create a tool that accounts for the bioc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::637d4623b2b71ae6a097d52eb99df8c2
https://pure.amc.nl/en/publications/the-sclerosing-cholangitis-outcomes-in-pediatrics-scope-index-a-prognostic-tool-for-children(92facea3-8fbb-41d6-adfd-46dfef3c90b7).html
https://pure.amc.nl/en/publications/the-sclerosing-cholangitis-outcomes-in-pediatrics-scope-index-a-prognostic-tool-for-children(92facea3-8fbb-41d6-adfd-46dfef3c90b7).html
Autor:
Uzma Shah, Kathleen M. Loomes, Nitika A. Gupta, Ellina Lytvyak, Eyal Shteyer, Pamela L. Valentino, Andréanne Zizzo, Mark Deneau, Melissa Zerofsky, Amy Taylor, Madeleine Aumar, Pushpa Sathya, Bart G. P. Koot, Matthew DiGuglielmo, Aldo J. Montano-Loza, Laura G. Draijer, Emily R. Perito, Amanda Ricciuto, Bernadette Vitola, Katryn N. Furuya, Nicholas Carman, Trevor J. Laborda, Mercedes Martinez, Tamir Miloh, Ruchi Singh
Publikováno v:
Paediatrics Publications
Journal of pediatric gastroenterology and nutrition, 71(4), 459-464. Lippincott Williams and Wilkins
Journal of pediatric gastroenterology and nutrition, 71(4), 459-464. Lippincott Williams and Wilkins
OBJECTIVES: Most patients with primary sclerosing cholangitis (PSC) also have inflammatory bowel disease (IBD). The liver and colon express MAdCAM-1, a target of lymphocyte homing integrins. Vedolizumab (VDZ) is an α4β7 integrin antibody used to tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b42b2190fbd89a22ff9dde4f369da115
https://ir.lib.uwo.ca/paedpub/529
https://ir.lib.uwo.ca/paedpub/529
Autor:
Cara L. Mack, Kathleen B. Schwarz, Jessica T. Hochberg, Wael El-Matary, Stacy Moroz, Trevor J. Laborda, Kathleen M. Loomes, Alexander Miethke, Girish S. Rao, Andréanne Zizzo, Nitika A. Gupta, Pamela L. Valentino, Nadia Ovchinsky, Nanda Kerkar, Pushpa Sathya, Mark Deneau, Ruchi Singh, Emily R. Perito, Achiya Z. Amir, Saeed Mohammed, Douglas Mogul, Matthew DiGuglielmo, Mercedes Martinez, Stephen L. Guthery, Bart G. P. Koot, Tamir Miloh, Simon Horslen, Amanda Ricciuto, Uzma Shah, Laura G. Draijer, Nisreen Soufi, Katryn N. Furuya
Publikováno v:
Clin Gastroenterol Hepatol
Inflammatory bowel disease (IBD), especially when associated with primary sclerosing cholangitis (PSC), is a risk factor for developing colorectal cancer (CRC).1-3 We aimed to determine the incidence of CRC in a large cohort of pediatric-onset PSC-ul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71edb6235905fa6e7985c72e14556ceb
https://doi.org/10.1016/j.cgh.2020.04.055
https://doi.org/10.1016/j.cgh.2020.04.055
Publikováno v:
Paediatrics Publications
BACKGROUND AND AIMS: Ten percent to 20% of children with autoimmune hepatitis (AIH) require second-line therapy to achieve remission. Although current guidelines exist on first-line management, evidence for second-line therapy in treatment-refractory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8fb33a2da0342466a4ca906058b0c22
https://ir.lib.uwo.ca/paedpub/78
https://ir.lib.uwo.ca/paedpub/78